Victory Capital Management Acquires Shares of Merit Medical Systems,

Trending News ☀️

Victory Capital Management Inc. recently announced that it has acquired shares of Merit Medical Systems ($NASDAQ:MMSI), Inc. Merit Medical Systems is a leading global medical device company that designs, develops, manufactures, and markets single-use medical devices used in interventional and diagnostic procedures. The company is focused on providing innovative products and services to healthcare providers worldwide. The company’s products and services range from small, disposable devices such as catheters and guidewires to complex diagnostic imaging systems. Merit Medical Systems has also established itself as a leader in the development of new technologies and procedures in the fields of cardiology, radiology, endoscopy, and vascular surgery. The firm is headquartered in Cleveland, Ohio and provides investment services to institutional investors, retail clients, and high net worth individuals.

Victory Capital Management is focused on delivering long-term investment solutions to its clients and has a long history of providing successful investments across a wide range of industries. The acquisition of shares in Merit Medical Systems by Victory Capital Management is part of the firm’s long-term strategy to invest in businesses that have the potential to create long-term value for its clients. With its strong product portfolio, innovative technology, and growing global presence, Merit Medical Systems is well-positioned to capitalize on the growing demand for medical devices worldwide. Victory Capital Management’s acquisition of shares of Merit Medical Systems further demonstrates its commitment to investing in companies with bright futures.

Price History

Victory Capital Management Inc. has recently acquired shares of Merit Medical Systems, Inc., and the news has been mostly positive. On Wednesday, Merit Medical Systems’ stock opened at $71.1 and closed at $71.9, up by 0.8% from its previous closing price of 71.4. The positive news is a testament to Merit Medical Systems’ strong reputation in the medical device industry. Their product portfolio includes interventional cardiology and radiology products, as well as endoscopy and respiratory items. Merit Medical Systems enjoys a strong presence in the medical device industry, providing quality products and services to medical professionals around the world.

This acquisition will further strengthen Merit Medical Systems’ presence in the industry, allowing them to expand their product offerings and reach more customers. Merit Medical Systems has a strong commitment to innovation and customer service, making them a great partner for Victory Capital Management Inc. With their combined expertise and resources, Victory and Merit can work together to develop new products and services that will benefit patients and healthcare providers alike. This acquisition is a sign of Victory’s confidence in Merit Medical Systems’ ability to deliver quality products and services to its customers. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for MMSI. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for MMSI. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for MMSI. More…

Key Ratios Snapshot

Some of the financial key ratios for MMSI are shown below. More…

Analysis

GoodWhale has conducted an analysis of the fundamentals of MERIT MEDICAL SYSTEMS and has given it a Risk Rating of medium. This means that while there may be some potential financial and business risks, they are manageable. GoodWhale has also identified two risk warnings in the income sheet and balance sheet of MERIT MEDICAL SYSTEMS. The company has been assessed on a variety of financial parameters to determine the level of risk associated with investing in it. These include the income statement, balance sheet, cash flow statement, and other financial statements. GoodWhale carefully examines the financial statements for any red flags that could indicate potential risks. GoodWhale’s risk assessment models also take into account the company’s industry, size, management, and competitive environment. This helps to give a comprehensive overview of the company’s financial health and potential risks. Investors can use the risk rating to assess their own risk tolerance when deciding whether to invest in MERIT MEDICAL SYSTEMS. It is important to note, however, that the risk rating should not be used as the only factor in making an investment decision. Other factors such as the company’s performance over time and its future prospects should also be taken into consideration. For a more detailed look at the financial health of MERIT MEDICAL SYSTEMS, investors can register on goodwhale.com to access the detailed analysis conducted by GoodWhale. This will provide an in-depth view of the company’s fundamental strengths and weaknesses and help investors make informed decisions. More…

Peers

The company’s products are used in a variety of medical procedures, including cardiovascular, gastrointestinal, urological, and obstetrical/gynecological procedures. The company has a strong competitive position in the medical device market, with a leading market share in many of its product categories.

However, the company faces competition from a number of well-established competitors, including Medeon Biodesign Inc, Pixium Vision SA, and AngioDynamics Inc.

– Medeon Biodesign Inc ($TPEX:6499)

Medeon Biodesign Inc is a medical device company that develops and commercializes products for the treatment of cardiovascular diseases. The company has a market cap of 4.55B and a ROE of -6.27%. Medeon Biodesign Inc’s products are used in the treatment of coronary artery disease, heart failure, and other cardiovascular conditions. The company’s products are sold in over 30 countries worldwide.

– Pixium Vision SA ($OTCPK:PXMVF)

Pixium Vision SA is a French company that designs, develops, and markets bionic vision systems to enable patients who have lost their sight to regain some level of vision. The company’s products include the PRIMA bionic vision system, which consists of an implantable microstimulator and a wearable camera and glasses, and the IRIS II bionic vision system, which consists of an implantable microstimulator and a contact lens. Pixium Vision SA’s products are intended for use in patients with retinitis pigmentosa, macular degeneration, and other degenerative eye diseases.

– AngioDynamics Inc ($NASDAQ:ANGO)

AngioDynamics Inc is a medical device company that designs, manufactures, and sells products used by interventional physicians to treat vascular diseases. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc has a market cap of 549.46M as of 2022, a Return on Equity of -5.11%. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc’s products are sold in over 50 countries worldwide.

Summary

Investing in Merit Medical Systems, Inc. has been a positive experience thus far, as evidenced by Victory Capital Management Inc. recently acquiring shares of the company. Merit Medical Systems has been performing well, with its stock price increasing steadily and its financials being in a healthy state. The company’s financial statements indicate strong growth potential and its products have been positively received by customers. Investors looking to diversify their portfolios may want to consider investing in Merit Medical Systems, as it appears to be a good long-term investment.